Fresh analysis indicates that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.
Published data in a leading health publication shows that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Individuals buying such treatments need to be informed of the potential of fast weight regain when the therapy ends," stated researcher Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment mass in about 18 months.
Weighing Treatments
The research, which reviewed dozens of trials involving over 9,000 of participants, compared the effects of the injectable medications with other pills.
Researchers emphasize that individuals who shed pounds through dieting typically experience a less rapid weight regain—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Doctors propose the mechanism of the drugs is key to understanding the accelerated rebound.
The injections copy a natural hormone called GLP-1, which moderates hunger.
"Artificially providing GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication results in hunger is unsuppressed, making binge eating much more probable."
An Ongoing Condition?
Health authorities recommend the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, considering the likelihood of relapse, the treatment might need to be long-term.
This view is echoed by drug manufacturers, who say that the results "highlight the long-term nature of excess weight," similar to managing diseases like hypertension.
User Experiences
Individuals who have discontinued the medication describe a intense return of appetite.
"It was like something activating and you're instantly ravenous," said one woman.
This difficulty is worsened if users have not developed lasting lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates suggest that millions of adults in the UK have used these injections in the past year, with desire remaining high.
- Use is greater among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
Finally, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on integrated lifestyle management.
